atropine has been researched along with 5-nitro-2-(3-phenylpropylamino)benzoic acid in 1 studies
Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (5-nitro-2-(3-phenylpropylamino)benzoic acid) | Trials (5-nitro-2-(3-phenylpropylamino)benzoic acid) | Recent Studies (post-2010) (5-nitro-2-(3-phenylpropylamino)benzoic acid) |
---|---|---|---|---|---|
26,711 | 1,259 | 1,697 | 561 | 0 | 90 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fischer, H; Illek, B; Machen, TE | 1 |
1 other study(ies) available for atropine and 5-nitro-2-(3-phenylpropylamino)benzoic acid
Article | Year |
---|---|
Intracellular Ca2+ signalling is modulated by K+ channel blockers in colonic epithelial cells (HT-29/B6).
Topics: Atropine; Calcium; Carbachol; Colonic Neoplasms; Epithelial Cells; Epithelium; Humans; Intracellular Membranes; Lanthanum; Lidocaine; Nitrobenzoates; Potassium Channels; Signal Transduction; Tumor Cells, Cultured | 1992 |